Argenx Se (ARGX) Consolidated Net Income (2016 - 2026)

Argenx Se (ARGX) posted Consolidated Net Income of $498.0 million for Q1 2026, down 6.56% on a QoQ basis from $532.9 million in Q4 2025, and up 145.96% year-over-year from $202.5 million in Q1 2025.

Argenx Se (ARGX) Consolidated Net Income (2016 - 2026) Analysis & Trends

Argenx Se's Consolidated Net Income history runs 11 years deep, the most recent figure standing at $498.0 million for Q1 2026.

  • Quarterly Consolidated Net Income rose 145.96% year-over-year to $498.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 55.66% YoY) and the FY2025 annual result came in at $1.3 billion, down 17.42% from the prior year.
  • Consolidated Net Income was $498.0 million for Q1 2026 at Argenx Se, down from $532.9 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $771.5 million in Q4 2024 and bottomed at -$665.9 million in Q2 2022.
  • A 5-year average of $160.4 million and a median of $123.5 million in 2023 frame the typical range for Consolidated Net Income.
  • Annual changes were most pronounced in 2022 — Consolidated Net Income sank 722.94% — and 2024, when it surged 3227.74%.
  • Argenx Se's Consolidated Net Income stood at $43.9 million in 2022, then tumbled by 47.14% to $23.2 million in 2023, then jumped by 3227.74% to $771.5 million in 2024, then plunged by 30.92% to $532.9 million in 2025, then declined by 6.56% to $498.0 million in 2026.
  • Business Quant data shows ARGX's Consolidated Net Income at $498.0 million in Q1 2026, $532.9 million in Q4 2025, and $344.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 498.00 Mn
Dec 31, 2025 532.95 Mn
Sep 30, 2025 344.26 Mn
Jun 30, 2025 328.44 Mn
Mar 31, 2025 202.47 Mn
Dec 31, 2024 771.50 Mn
Sep 30, 2024 91.41 Mn
Jun 30, 2024 29.07 Mn
Mar 31, 2024 -61.60 Mn
Dec 31, 2023 23.18 Mn
Sep 30, 2023 93.92 Mn
Jun 30, 2023 -94.37 Mn
Mar 31, 2023 123.49 Mn
Dec 31, 2022 43.86 Mn
Sep 30, 2022 247.01 Mn
Jun 30, 2022 -665.94 Mn
Mar 31, 2022 218.89 Mn
Dec 31, 2021 -237.82 Mn
Sep 30, 2021 233.62 Mn
Jun 30, 2021 106.90 Mn